Publications | PubMed=8289498 Wada H., Asada M., Nakazawa S., Itoh H., Kobayashi Y., Inoue T., Fukumuro K., Chan L.C., Sugita K., Hanada R., Akuta N., Kobayashi N., Mizutani S. Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia 8:53-59(1994) PubMed=10360377; DOI=10.1038/sj.leu.2401437 Nakamura M., Sugita K., Inukai T., Goi K., Iijima K., Tezuka T., Kojika S., Shiraishi K., Miyamoto N., Karakida N., Kagami K., Koyama-Okazaki T., Mori T., Nakazawa S. p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation. Leukemia 13:884-890(1999) PubMed=10490826; DOI=10.1038/sj.onc.1202874 Fu X.-Y., McGrath S., Pasillas M., Nakazawa S., Kamps M.P. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene 18:4920-4929(1999) PubMed=10995006; DOI=10.1038/sj.leu.2401893 Iijima K., Sugita K., Inukai T., Goi K., Tezuka T., Uno K., Sato H., Kagami K., Nakazawa S. Expression of thrombopoietin receptor and its functional role in human B-precursor leukemia cells with 11q23 translocation or Philadelphia chromosome. Leukemia 14:1598-1605(2000) DOI=10.1016/B978-0-12-221970-2.50457-5 Drexler H.G. The leukemia-lymphoma cell line factsbook. (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001) PubMed=20519628; DOI=10.1182/blood-2009-09-244673 Hirose K., Inukai T., Kikuchi J., Furukawa Y., Ikawa T., Kawamoto H., Oram S.H., Gottgens B., Kiyokawa N., Miyagawa Y., Okita H., Akahane K., Zhang X.-C., Kuroda I., Honna H., Kagami K., Goi K., Kurosawa H., Look A.T., Matsui H., Inaba T., Sugita K. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19). Blood 116:962-970(2010) PubMed=20575032; DOI=10.1002/ajh.21738; PMCID=PMC7159455 Inukai T., Zhang X.-R., Kameyama T., Suzuki Y., Yoshikawa K., Kuroda I., Nemoto A., Akahane K., Sato H., Goi K., Nakamoto K., Hamada J.-i., Tada M., Moriuchi T., Sugita K. A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines. Am. J. Hematol. 85:535-537(2010) PubMed=29786757; DOI=10.1007/s12185-018-2474-7 Tomoyasu C., Imamura T., Tomii T., Yano M., Asai D., Goto H., Shimada A., Sanada M., Iwamoto S., Takita J., Minegishi M., Inukai T., Sugita K., Hosoi H. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes. Int. J. Hematol. 108:312-318(2018) PubMed=35124168; DOI=10.1016/j.jsbmb.2022.106068 Tamai M., Kasai S., Akahane K., Thu T.N., Kagami K., Komatsu C., Abe M., Watanabe A., Goi K., Miyake K., Inaba T., Takita J., Goto H., Minegishi M., Iwamoto S., Sugita K., Inukai T. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia. J. Steroid Biochem. Mol. Biol. 218:106068.1-106068.12(2022) |